Refractory henoch–schÖnlein purpura: atypical aetiology and management
ConclusionRituximab might be efficacious in treatment of hspn, more studies are needed to assess long‐term safetey and efficacy.
Source: Journal of Renal Care - Category: Urology & Nephrology Authors: Amr El‐Husseini, Ahmed Ahmed, Alberto Sabucedo, Edward Fabulo Tags: Case Report Source Type: research
More News: Glomeruli | Hypertension | Lisinopril | Nephritis | Rituxan | Study | Urology & Nephrology